Latest Capital Raises News

US1 Critical Minerals reports ongoing legal disputes over US rare earth tenements while advancing Tanzanian uranium exploration and securing $1.5 million in new capital.

Green Technology Metals (ASX, GT1) has made significant strides in its Seymour Lithium Project with a successful $4.5 million capital raise, appointment of Altris Engineering for DFS completion, and a 45% reduction in project footprint. These developments come as lithium prices surge, positioning GT1 to become Ontario’s first lithium producer.

Terra Metals reports breakthrough high-grade platinum group metals discoveries at its Southwest Prospect and confirms resource growth at its Dante Project, backed by a robust $11 million cash position.

Ava Risk Group reports a softer first half with delayed orders impacting revenue, but anticipates a robust recovery in the second half backed by new contracts and a strategic investment.

Horizon Minerals Ltd reported a solid quarterly cash flow increase of A$3.1 million, ending December 2025 with A$37.5 million in cash and equivalents. The company also extinguished its Nebari Convertible Loan Facility, signaling a cleaner capital structure ahead.

WAM Active Limited has announced a significant capital raising through a pro-rata entitlement offer and a placement, aiming to bolster its investment capacity without materially affecting company control.

QMines Limited has made significant strides in its Queensland projects with high-grade drilling results at Mount Mackenzie and Develin Creek, backed by a $9 million capital raise to support exploration and development.

CuFe Ltd has raised $5.4 million through a strategic placement and upgraded its Tennant Creek resource to include valuable critical minerals, setting the stage for a major drilling campaign.

Nutritional Growth Solutions reports improved cash flow and cost savings amid leadership changes, setting the stage for renewed growth in FY26.

Saturn Metals has delivered a strong Pre-Feasibility Study for its Apollo Hill Gold Project, outlining a 1.77 million ounce production target and maiden Ore Reserve of 1.58 million ounces. The company also completed a well-supported A$45 million share placement, positioning it well for the next development phase.

Imugene Limited has reported compelling clinical trial results for its off-the-shelf CAR T therapy, azer-cel, alongside FDA validation and a strategic collaboration, while managing cash flow amid cost reductions.

Volt Group Limited has reported record full-year revenue for CY25, bolstered by the strategic acquisition of digital inspection firm 4D Delta and strong performances across its mining technology businesses.